Consumers are often deceived by the "Maximum Strength" claims and do not seek prescription-grade treatment, the lidocaine patch class action lawsuit claims.
Rite-Aid faces a class action lawsuit over Lidocaine pain relief patches sold under the pharmacy’s private label, which were marketed as “Maximum Strength”, with allegedly false and misleading information about the dosing strengths that were intended to deceive customers.
The complaint (PDF) was filed by Steven Prescott in the U.S. District Court for the Northern District of California on October 6, seeking damages on behalf of himself and all others who have paid a premium for Rite Aid Maximum Strength Pain Relief Lidocaine Patch products, since there were stronger dosed pain relief patches commercially available.
Lidocaine patches are a popular household pain management option, to provide relief for individuals with nerve pain. It is estimated that millions of Americans suffer from multiple types of neuropathic pain, who frequently seek over-the-counter remedies.
In recent months, a series of Lidocaine patch false advertising lawsuits have been filed against retailers including Walmart, Walgreens and now Rite Aid. The lawsuits have all raised fairly similar allegations, claiming retailers take advantage of consumers seeking pain relief products by using false claims on the product packaging that exaggerate strength, duration of effectiveness and ease of use.
Side effects of Tylenol may cause autism and ADHD among...
Apple is set to pay $250 million to settle a lawsuit accusing the company of overselling Siri's artificial intelligence abilities on newer iPhones. According to MacRumors, the proposed class-actio...